Condition: Transition Cell Cancer · Sponsor: Armed Forces Institute of Urology, Rawalpindi
As every urologist does transurethral resection of bladder tumor. So there are instances in which the operating surgeon is not sure whether the normal-looking mucosa or the inflammatory changes are really benign or if we are missing the CIS/bladder cancer.
This description comes directly from the study's public registry record.
azmat ullah, consultant urologist · +923329354338 · azmatdawar254@gmail.com
ullah · azmatdawar254@gmail.com
Always discuss trial participation with your own doctor first.
| Armed Forces Institute of Urology | Rawalpindi, Punjab Province, Pakistan | Recruiting |
| Armed Forces Institute of Urology | Rawalpindi, Punjab Province, Pakistan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06729346